Form 4: Sunshine Biopharma Director Receives Stock Grant
Insider Transaction (Form 4)
David Natan, a Director of Sunshine Biopharma Inc., received 58,300 shares of common stock on August 7, 2026.
Summary
- Grant/award: acquired 58,300 Common Stock on August 7, 2026; holds 68,300 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
David Natan — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Grant/award | Common Stock | 58,300 | — | — | 68,300 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Grant/award (58,300 shares) |
Keywords
insider transaction, Form 4, SBFM, Sunshine Biopharma Inc., neutral, David Natan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.